It’s a Match!
Fourth-year medical students at Baylor College of Medicine learned where they will conduct their residency training, and their matches revealed a strong focus on primary care fields.
Study of LDL lowering drug found no increase of adverse events
A study looking at the safety of a new drug has found it does not increase overall adverse events or serious adverse events when compared to placebo.
Ketamine-based nasal spray to treat depression
A Baylor College of Medicine expert discusses the potential impact of the new ketamine-based treatment recently approved by the FDA, which is being marketed as the first fast-acting depression drug.
Shortages of pediatric cancer medicines threaten outcomes
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals across the country.
Researchers uncover aspirin’s effects on platelet rich plasma
A collaborative study led by researchers at Baylor College of Medicine explores the effects of aspirin on a new biologic therapy, platelet rich plasma (PRP).
